Vanguard Personalized Indexing Management, LLC
Position in TCRX — TScan Therapeutics, Inc.
CIK 1767306
OAKLAND, CA
Position in TCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$17,599
-$3,973 QoQ
Shares Held
17,959
-15.9% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 60 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $98,300,353 across 139 Biotechnology names. TCRX ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,151 | $21,434,396 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,712 | $7,302,900 | |
| 3 | INCY |
Incyte Corp
|
34,556 | $3,917,268 | |
| 4 | ARGX |
Argenx SE
|
4,103 | $3,806,640 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,436 | $3,442,579 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,697 | $3,314,294 | |
| 7 | MRNA |
Moderna, Inc.
|
43,679 | $3,058,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
30,414 | $2,380,503 |
All Filings in TCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,599 | 17,959 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $21,572 | 21,359 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,677 | 14,677 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $38,205 | 20,992 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $28,843 | 19,892 | Shares | Sole | 2025-07-25 | |
| No filing history on record for this holder in this stock. | ||||||